American Journal of Epidemiology Vol. 143, No. 10: 1059-1068
Copyright © 1996 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Adjusting Survival Curves for Confounders: A Review and a New Method
1Department of Epidemiology, School of Hygiene and Public Health, The Johns Hopkins University Baltimore, MD
2Department of Medicine, School of Medicine, The Johns Hopkins University Baltimore, MD
Reprint requests to Dr. F. Javier Nieto, Department of Epidemiology, JHU School of Hygiene and Public Health, 615 North Wolfe Street, Baltimore, MD 21205.
When reporting results from survival analysis, investigators often present crude Kaplan-Meier survival curves and adjusted relative hazards from the Cox proportional hazards model. Occasionally, the investigators will also provide a graphical representation of adjusted survival curves based on regression estimates and the average covariate values in the study groups. In this paper, the authors review the limitations of this approach and examine alternative approaches to obtaining adjusted survival curves that have been proposed. Furthermore, a new method to obtain multivariate adjusted survival curves is described. This method is based on direct adjustment of the observed conditional probability of survival at the time of each event. When an unexposed group is used as a standard for adjusting an exposed group, the survival curve in the exposed group is adjusted to the covariate distribution among the unexposed at the time of the event. This method has the advantage over the average covariate method of allowing for the possibility that the adjusted survival curves differ in shape. The method can handle multiple fixed or time-dependent categorical covariates as well as left truncated data, and it allows for estimation of confidence intervals. The authors have written a macro in SAS language that produces the adjusted survival estimates and graphs. This macro is available on request and can be downloaded through the World Wide Web.
confounding factors (epidemiology); data display; epidemiologic methods; graphical analysis; proportional hazards models; prospective studies; regression analysis; survival analysis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S.-G. Yeo, J.-S. Kim, M.-J. Cho, K.-H. Kim, and J.-S. Kim Interstitial Fluid Pressure as a Prognostic Factor in Cervical Cancer Following Radiation Therapy Clin. Cancer Res., October 1, 2009; 15(19): 6201 - 6207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli, F. Sacks, M. Arnold, L. Moye, B. Davis, M. Pfeffer, and for the Cholesterol and Recurrent Events (CARE) Tr Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease Circulation, January 15, 2008; 117(2): 163 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Mangano, Y. Miao, A. Vuylsteke, I. C. Tudor, R. Juneja, D. Filipescu, A. Hoeft, M. L. Fontes, Z. Hillel, E. Ott, et al. Mortality Associated With Aprotinin During 5 Years Following Coronary Artery Bypass Graft Surgery JAMA, February 7, 2007; 297(5): 471 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli, P. Jose, G. Curhan, F. Sacks, E. Braunwald, M. Pfeffer, and Cholesterol and Recurrent Events (CARE) Trial Inve Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial BMJ, June 17, 2006; 332(7555): 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli, F. Sacks, M. Pfeffer, Z. Gao, G. Curhan, and for the Cholesterol And Recurrent Events (CARE) Tr Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease Circulation, October 25, 2005; 112(17): 2627 - 2633. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Beinart, P. Kolm, E. Veledar, Z. Zhang, E. M. Mahoney, O. Bouin, S. Gabriel, J. Jackson, R. Chen, J. Caro, et al. Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention: Results From the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial J. Am. Coll. Cardiol., September 6, 2005; 46(5): 761 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Weintraub, E. M. Mahoney, A. Lamy, S. Culler, Y. Yuan, J. Caro, S. Gabriel, S. Yusuf, and CURE Study Investigators Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation J. Am. Coll. Cardiol., March 15, 2005; 45(6): 838 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli, B. Hemmelgarn, B. Manns, S. Davison, C. Bohm, S. Gourishankar, G. Pylypchuk, K. Yeates, and J. S. Gill Use and Outcomes of Peritoneal Dialysis among Aboriginal People in Canada J. Am. Soc. Nephrol., February 1, 2005; 16(2): 482 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abrahamowicz, R. du Berger, D. Krewski, R. Burnett, G. Bartlett, R. M. Tamblyn, and K. Leffondre Bias due to Aggregation of Individual Covariates in the Cox Regression Model Am. J. Epidemiol., October 1, 2004; 160(7): 696 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, J. Coresh, J. A. Eustace, J. C. Longenecker, B. Jaar, N. E. Fink, R. P. Tracy, N. R. Powe, and M. J. Klag Association Between Cholesterol Level and Mortality in Dialysis Patients: Role of Inflammation and Malnutrition JAMA, January 28, 2004; 291(4): 451 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Haroun, B. G. Jaar, S. C. Hoffman, G. W. Comstock, M. J. Klag, and J. Coresh Risk Factors for Chronic Kidney Disease: A Prospective Study of 23,534 Men and Women in Washington County, Maryland J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2934 - 2941. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Vivekananthan, E. H. Blackstone, C. E. Pothier, and M. S. Lauer Heart rate recovery after exercise is apredictor of mortality, independent of the angiographic severity of coronary disease J. Am. Coll. Cardiol., September 3, 2003; 42(5): 831 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Cheng, M. S. Lauer, C. P. Earnest, T. S. Church, J. B. Kampert, L. W. Gibbons, and S. N. Blair Heart Rate Recovery Following Maximal Exercise Testing as a Predictor of Cardiovascular Disease and All-Cause Mortality in Men With Diabetes Diabetes Care, July 1, 2003; 26(7): 2052 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Brown, A. R. Levy, Z. Rosberger, and L. Edgar Psychological Distress and Cancer Survival: A Follow-Up 10 Years After Diagnosis Psychosom Med, July 1, 2003; 65(4): 636 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Manjunath, H. Tighiouart, H. Ibrahim, B. MacLeod, D. N. Salem, J. L. Griffith, J. Coresh, A. S. Levey, and M. J. Sarnak Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community J. Am. Coll. Cardiol., January 1, 2003; 41(1): 47 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Spence, M. Eliasziw, M. DiCicco, D. G. Hackam, R. Galil, and T. Lohmann Carotid Plaque Area: A Tool for Targeting and Evaluating Vascular Preventive Therapy Stroke, December 1, 2002; 33(12): 2916 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Ghali, P. D. Faris, P. D. Galbraith, C. M. Norris, M. J. Curtis, L. D. Saunders, V. Dzavik, L. B. Mitchell, M. L. Knudtson, and for the Alberta Provincial Project for Outcome Ass Sex Differences in Access to Coronary Revascularization after Cardiac Catheterization: Importance of Detailed Clinical Data Ann Intern Med, May 21, 2002; 136(10): 723 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sundararajan, N. Mitra, J. S. Jacobson, V. R. Grann, D. F. Heitjan, and A. I. Neugut Survival Associated with 5-Fluorouracil-Based Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer Ann Intern Med, March 5, 2002; 136(5): 349 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Ghali, H. Quan, R. Brant, G. van Melle, C. M. Norris, P. D. Faris, P. D. Galbraith, M. L. Knudtson, and for the APPROACH Investigators Comparison of 2 Methods for Calculating Adjusted Survival Curves From Proportional Hazards Models JAMA, September 26, 2001; 286(12): 1494 - 1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.C Lampe, P.H Whincup, S.G Wannamethee, A.G Shaper, M Walker, and S Ebrahim The natural history of prevalent ischaemic heart disease in middle-aged men Eur. Heart J., July 1, 2000; 21(13): 1052 - 1062. [Abstract] [PDF] |
||||
![]() |
D. R. Thiemann, J. Coresh, W. J. Oetgen, and N. R. Powe The Association between Hospital Volume and Survival after Acute Myocardial Infarction in Elderly Patients N. Engl. J. Med., May 27, 1999; 340(21): 1640 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. CLOUTIER, P. SABOURET, and A. DEGHRAR Total Knee Arthroplasty with Retention of Both Cruciate Ligaments. A Nine to Eleven-Year Follow-up Study J. Bone Joint Surg. Am., May 1, 1999; 81(5): 697 - 702. [Abstract] [Full Text] |
||||













